Characterization and evaluation of a new oncolytic Vaccinia Virus strain LIVP6.1.1 for canine cancer therapy

References

• Merlo DF, Rossi L, Pellegrino C, Ceppi M, Cardellino U, Capurro C, et al. Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy. J Vet Intern Med 2008; 22:976 - 84; http://dx.doi.org/10.1111/j.1939-1676.2008.0133.x; PMID: 18564221
   PubMed Web of Science ®Google Scholar
• Kelsey JL, Moore AS, Glickman LT. Epidemiologic studies of risk factors for cancer in pet dogs. Epidemiol Rev 1998; 20:204 - 17; http://dx.doi.org/10.1093/oxfordjournals.epirev.a017981; PMID: 9919439
   PubMed Web of Science ®Google Scholar
• Ternovoi VV, Le LP, Belousova N, Smith BF, Siegal GP, Curiel DT. Productive replication of human adenovirus type 5 in canine cells. J Virol 2005; 79:1308 - 11; http://dx.doi.org/10.1128/JVI.79.2.1308-1311.2005; PMID: 15613357
   PubMed Web of Science ®Google Scholar
• Smith BF, Curiel DT, Ternovoi VV, Borovjagin AV, Baker HJ, Cox N, et al. Administration of a conditionally replicative oncolytic canine adenovirus in normal dogs. Cancer Biother Radiopharm 2006; 21:601 - 6; http://dx.doi.org/10.1089/cbr.2006.21.601; PMID: 17257075
   PubMed Web of Science ®Google Scholar
• Le LP, Rivera AA, Glasgow JN, Ternovoi VV, Wu H, Wang M, et al. Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells. Gene Ther 2006; 13:389 - 99; http://dx.doi.org/10.1038/sj.gt.3302674; PMID: 16292351
   PubMed Web of Science ®Google Scholar
• Suter SE, Chein MB, von Messling V, Yip B, Cattaneo R, Vernau W, et al. In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma. Clin Cancer Res 2005; 11:1579 - 87; http://dx.doi.org/10.1158/1078-0432.CCR-04-1944; PMID: 15746063
   PubMed Web of Science ®Google Scholar
• Gentschev I, Ehrig K, Donat U, Hess M, Rudolph S, Chen N, et al. Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68. J Oncol 2010; 2010:736907; http://dx.doi.org/10.1155/2010/736907; PMID: 20631910
   PubMedGoogle Scholar
• Gentschev I, Stritzker J, Hofmann E, Weibel S, Yu YA, Chen N, et al. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther 2009; 16:320 - 8; http://dx.doi.org/10.1038/cgt.2008.87; PMID: 18949014
   PubMed Web of Science ®Google Scholar
• Gentschev I, Müller M, Adelfinger M, Weibel S, Grummt F, Zimmermann M, et al. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68. PLoS One 2011; 6:e22069; http://dx.doi.org/10.1371/journal.pone.0022069; PMID: 21779374
   PubMed Web of Science ®Google Scholar
• Patil SS, Gentschev I, Adelfinger M, Donat U, Hess M, Weibel S, et al. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody. PLoS One 2012; e47472
   Google Scholar
• Arendt M, Nasir L, Morgan IM. Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks. Vet Comp Oncol 2009; 7:153 - 61; http://dx.doi.org/10.1111/j.1476-5829.2009.00187.x; PMID: 19691644
   PubMed Web of Science ®Google Scholar
• Patil SS, Gentschev I, Nolte I, Ogilvie G, Szalay AA. Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients. J Transl Med 2012; 10:3; http://dx.doi.org/10.1186/1479-5876-10-3; PMID: 22216938
   PubMed Web of Science ®Google Scholar
• Gil M, Bieniasz M, Seshadri M, Fisher D, Ciesielski MJ, Chen Y, et al. Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice. Br J Cancer 2011; 105:1512 - 21; http://dx.doi.org/10.1038/bjc.2011.429; PMID: 21989183
   PubMed Web of Science ®Google Scholar
• Breitbach CJ, Paterson JM, Lemay CG, Falls TJ, McGuire A, Parato KA, et al. Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. Mol Ther 2007; 15:1686 - 93; http://dx.doi.org/10.1038/sj.mt.6300215; PMID: 17579581
   PubMed Web of Science ®Google Scholar
• Gentschev I, Adelfinger M, Josupeit R, Rudolph S, Ehrig K, Donat U, et al. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma. PLoS One 2012; 7:e37239; http://dx.doi.org/10.1371/journal.pone.0037239; PMID: 22615950
   PubMedGoogle Scholar
• Reimann-Berg N, Willenbrock S, Murua Escobar H, Eberle N, Gerhauser I, Mischke R, et al. Two new cases of polysomy 13 in canine prostate cancer. Cytogenet Genome Res 2011; 132:16 - 21; http://dx.doi.org/10.1159/000317077; PMID: 20668368
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yu YA, Wang E, Chen N, Danner RL, Munson PJ, et al. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res 2007; 67:10038 - 46; http://dx.doi.org/10.1158/0008-5472.CAN-07-0146; PMID: 17942938
   PubMed Web of Science ®Google Scholar
• Gentschev I, Donat U, Hofmann E, Weibel S, Adelfinger M, Raab V, et al. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68. J Biomed Biotechnol 2010; 2010:489759; http://dx.doi.org/10.1155/2010/489759; PMID: 20379368
   PubMed Web of Science ®Google Scholar
• Weibel S, Stritzker J, Eck M, Goebel W, Szalay AA. Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment. Cell Microbiol 2008; 10:1235 - 48; http://dx.doi.org/10.1111/j.1462-5822.2008.01122.x; PMID: 18208564
   PubMed Web of Science ®Google Scholar
• Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010; 22:238 - 44; http://dx.doi.org/10.1016/j.coi.2010.01.021; PMID: 20171075
   PubMed Web of Science ®Google Scholar